Enzalutamide Monotherapy for the Treatment of Prostate Cancer with High-Risk Biochemical Recurrence: EMBARK Secondary End Points: Erratum
Year: 2026
Type: erratum
Source: The Journal of Urology
Authors: Neal D. Shore, Ugo De Giorgi, Ronald F. Tutrone, James L. Bailen, Erik P. M. Roos, Ján Kliment, Gavin Marx, Lawrence I. Karsh, Miguel Ramirez-Backhaus, Edward M. Uchio, Stéphane Supiot, Yiyun Tang, Brad Rosbrook, Gabriel P. Haas, Matt Rosales, Fabian Zohren, Jamal Tarazi, Stephen J. Freedland
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7167807089